Bengaluru-Based Lamark Biotech Raises Rs 6.5 Crore to Transform Biologic Therapies
In a breakthrough moment for India’s biotech ecosystem, Lamark Biotech has secured Rs 6.5 crore in its pre-Series A funding round. The round, led by IAN Group—through funds like IAN Alpha and BioAngels—also saw participation from notable angel investors, including Dr. Vinayender Tulla, Dr. Nita Roy, and…
